Scitech | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

492 results for “Scitech”

Trials

View all 419 →

Evaluating the Use of a Medication 'Switch' vs Guideline-directed Interventions for Relieving Side Effects of Aromatase Inhibitors Among Breast Cancer Patients

62 participants · First posted Jul 17, 2025

Not yet recruiting

Multimodal Imaging Evaluation and Prognostic Analysis of Participants After Arterial Switch Operation

1,000 participants · First posted Jul 28, 2021

MAIN STUDY: SWITCH SUB-STUDY: SWITCH-JCV

55 participants · First posted Oct 28, 2013

Drugs

View all 13 →

Sci-DaPT vaccine(Scitech Genetics)

Sci-DaPT-Hep B vaccine (Scitech Genetics)

Organizations

View all 12 →

SciTech Development LLC

United States

American Scitech Incorporated

United States

Jilin Province Xidian Pharmaceutical SciTech Development Co.,Ltd

News

View all 48 →

SciTech Development Appoints John Chapman to Strategic Advisory Board

Bruntwood SciTech Completes £60m Greenheys Lab, Ushering UK Biobank's New Manchester Headquarters

SciTech Development's ST-001 nanoFenretinide Advances to Phase 1b for T-Cell Lymphomas

Page 1 of 50